Cargando…

Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison

BACKGROUND: Cytokine storm is a marker of severity and severe mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia. Immunomodulatory treatments may reduce morbidity and mortality. OBJECTIVES: To determine whether a 7-day course of methylprednisolone (MP) administered with and wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamed, Dujana Mostafa, Belhoul, Khawla Mohammad, Al Maazmi, Naama Abdelrahman, Ghayoor, Farah, Moin, Muneeba, Al Suwaidi, Mahra, Narainen, Meeruna, Makki, Maryam, AbdulRahman, Mahera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191304/ https://www.ncbi.nlm.nih.gov/pubmed/34153729 http://dx.doi.org/10.1016/j.jiph.2021.06.003

Ejemplares similares

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Lack of efficacy: case report
Publicado: (2021)

Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
por: Akiyama, Kaho, et al.
Publicado: (2021)

Pattern and determinants of contraceptive usage among women of reproductive age in the United Arab Emirates
por: Abdulrahman, Mahera, et al.
Publicado: (2019)

Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Fungal sepsis and pseudomonal pneumonia: 2 case reports
Publicado: (2021)

Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution
por: Ichiyama, Takashi, et al.
Publicado: (2022)

Large variations in disease severity, death and ICU admission of 2993 patients infected with SARS-CoV-2: The potential impact of genetic vulnerability
por: Farajallah, Halah Mohammed, et al.
Publicado: (2021)

Ciclosporin/methylprednisolone/tocilizumab: COVID-19 pneumonia, leukopenia and neutropenia: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021)

Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19
por: Abbasian, Ladan, et al.
Publicado: (2022)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis
por: Ghoraba, Hashem H, et al.
Publicado: (2022)

Intravenous pulse methylprednisolone for the treatment of severe COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2023)

Methylprednisolone/tocilizumab: Herpes Simplex virus type I reactivation and hyperglycaemia: 2 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Methicillin-sensitive Staphylococcus aureus costochondritis and chest wall abscess: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Publicado: (2022)

High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
por: Kawada, Sanami, et al.
Publicado: (2013)

Use of tocilizumab, remdesivir, and high-dose methylprednisolone prevents intubation in an ESRD patient with COVID-19 pneumonia
por: Judge, Ramzan, et al.
Publicado: (2022)

Population awareness of cardiovascular disease risk factors and health care seeking behavior in the UAE
por: Kazim, Mahra Nooruddin, et al.
Publicado: (2021)

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
por: Lauper, Kim, et al.
Publicado: (2018)

Hepatotoxicity after high‐dose intravenous methylprednisolone in multiple sclerosis patients
por: Hidalgo de la Cruz, Milagros, et al.
Publicado: (2017)

Correction: Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
Publicado: (2019)

Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: Single center cohort study of 685 patients
por: Luis, Buzon-Martín, et al.
Publicado: (2021)

Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
por: Prakash, Sanjay, et al.
Publicado: (2009)

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
por: Eguchi, Hiroyuki, et al.
Publicado: (2015)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
por: Walasik-Szemplińska, Dorota, et al.
Publicado: (2019)

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
por: Sakoulas, George, et al.
Publicado: (2020)

Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2023)

Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons
por: Al Shaer, Laila, et al.
Publicado: (2017)

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
por: Burmester, Gerd R, et al.
Publicado: (2016)

Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: A case report
por: Al-Mashdali, Abdulrahman F., et al.
Publicado: (2021)

Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with vasculitis of rheumatic disease
por: Rouster-Stevens, KA, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_tgd29qmd7li2sinvkb46m5rbu6